STXS - צמיחת הכנסות ב-12 חודשים נגררים Stereotaxis Corporation

Stereotaxis, Inc. (STXS) focuses on technological alliances and the integration of its software into third-party navigation systems. Revenue is generated through the sale of Genesis robots and associated consumables for cardiac surgery. Cost optimization is achieved via contract electronics manufacturing and outsourced logistics. The trailing twelve months (TTM) annual growth in operating sales revenue demonstrates a recovery trend, where 4.80 captures the current value of the indicator.
stereotaxis.com (STXS) - פילוחי מדדים ודוחות פיננסיים

Stereotaxis, Inc. (STXS) ability to attract leading roboticists to develop precision surgical systems translates directly into market share expansion and revenue growth. By analyzing the year-over-year dynamics of commercial revenues on a rolling basis, an investor can observe the percentage change in total sales over the last 12 months, allowing for an objective assessment of the business scaling pace and the company's fundamental stability.